ArticleOpen forum infectious diseases2024

Real-World Dalbavancin Use for Serious Gram-Positive Infections: Comparing Outcomes Between People Who Use and Do Not Use Drugs.

Sarah Zambrano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.